Related Experiment Video
Updated: Jun 2, 2026

12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Liver transplantation with donors older than 75 years
B Sampedro1, J Cabezas, E Fábrega
1University Hospital Marqués de Valdecilla, Faculty of Medicine, Santander, Spain.
Transplantation Proceedings
|April 14, 2011
Summary
Using elderly donors (≥ 75 years) for liver transplantation did not significantly impact patient survival. However, careful donor selection is crucial to mitigate risks associated with older donor livers, such as poorer initial graft function.
Area of Science:
- Hepatology
- Transplant Surgery
- Geriatric Medicine
Background:
- Orthotopic liver transplantation (OLT) outcomes have improved, increasing demand for donor organs.
- Expanded donor criteria, including elderly donors, are utilized to address organ shortages.
- This study evaluates the use of older donors in OLT.
Purpose of the Study:
- To compare clinical outcomes and survival rates between liver grafts from donors aged ≥ 75 years and younger donors.
- To analyze donor and recipient characteristics in OLT using elderly donors.
Main Methods:
- Retrospective analysis of 174 consecutive OLTs performed between 2001 and 2009.
- Comparison of outcomes for 24 liver grafts from donors ≥ 75 years versus younger donors.
- Evaluation of donor/recipient factors, clinical evolution, and survival.
Main Results:
- Overall survival rates were similar between older (≥ 75 years) and younger donor groups (69% vs. 63% at 5 years).
- No significant differences in ICU stay, ischemia times, or transfusion requirements were observed.
- Older donor livers were associated with higher rates of poor initial graft function and increased reinterventions.
Conclusions:
- Donor age alone does not appear to confer a survival disadvantage in OLT.
- Careful selection of elderly donors is essential to minimize procedural risks.
- While elderly donors expand the donor pool, potential complications require vigilant management.
Related Concept Videos
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
